Brevan Howard Capital Management LP Rocket Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 25,147 shares of RCKT stock, worth $212,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,147
Previous 16,720
50.4%
Holding current value
$212,743
Previous $308,000
2.6%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$150 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$118 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$55.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$52.4 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$44 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $640M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...